Drug
Reslizumab
Reslizumab: highest development phase Phase 2/3, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Reslizumab NCT00538434 | Phase 2/3 | Eosinophilic Esophagitis |
Latest
No recent events.
Follow Reslizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.